NARYSHKIN; Nikolai

Patent Applications and Registrations

Patent applications and USPTO patent grants for NARYSHKIN; Nikolai.The latest application filed is for "compounds for treating spinal muscular atrophy".

Company Profile

9.16.18

NARYSHKIN; Nikolai - East Brunswick NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds For Treating Spinal Muscular Atrophy App 20210276999 - QI; Hongyan ; et al.	2021-09-09
Methods For Modulating Rna Splicing App 20210069350 - Naryshkin; Nikolai ; et al.	2021-03-11
Compounds for treating spinal muscular atrophy Grant 10,851,101 - Qi , et al. December 1, 2	2020-12-01
Methods For Modifying Rna Splicing App 20200370043 - BHATTACHARYYA; Anuradha ; et al.	2020-11-26
Methods for modulating the amount of RNA transcripts Grant 10,688,099 - Naryshkin	2020-06-23
Methods for modulating RNA splicing Grant 10,668,171 - Naryshkin , et al.	2020-06-02
Compounds For Treating Spinal Muscular Atrophy App 20190375750 - QI; Hongyan ; et al.	2019-12-12
Compounds for treating spinal muscular atrophy Grant 10,501,482 - Dakka , et al. Dec	2019-12-10
Compounds for treating spinal muscular atrophy Grant RE47,689 - Woll , et al. No	2019-11-05
Methods For Modulating Rna Splicing App 20190330615 - Bhattacharyya; Anuradha ; et al.	2019-10-31
Methods For Modulating The Amount Of Rna Transcripts App 20190134045 - Naryshkin; Nikolai	2019-05-09
Methods for modulating the amount of RNA transcripts Grant 10,195,202 - Naryshkin Fe	2019-02-05
Compounds For Treating Spinal Muscular Atrophy App 20180222925 - Dakka; Amal ; et al.	2018-08-09
Methods For Modulating Rna Splicing App 20180161456 - Naryshkin; Nikolai ; et al.	2018-06-14
Compounds For Treating Spinal Muscular Atrophy App 20180105526 - QI; Hongyan ; et al.	2018-04-19
Compounds for treating spinal muscular atrophy Grant 9,879,007 - Qi , et al. January 30, 2	2018-01-30
Compounds For Treating Spinal Muscular Atrophy App 20170129885 - QI; Hongyan ; et al.	2017-05-11
Compounds for treating spinal muscular atrophy Grant 9,617,268 - Woll , et al. April 11, 2	2017-04-11
Compounds for treating spinal muscular atrophy Grant 9,586,955 - Qi , et al. March 7, 2	2017-03-07
Methods For Modulating The Amount Of Rna Transcripts App 20170000794 - NARYSHKIN; Nikolai	2017-01-05
Methods and agents for screening for compounds capable of modulating gene expression Grant 9,476,870 - Cao , et al. October 25, 2	2016-10-25
Compounds for treating spinal muscular atrophy Grant 9,399,649 - Chen , et al. July 26, 2	2016-07-26
Methods of screening for compounds for treating muscular dystrophy using human ALPHA7 integrin mRNA translation regulation Grant 9,376,725 - Friesen , et al. June 28, 2	2016-06-28
Compounds For Treating Spinal Muscular Atrophy App 20160145270 - Dakka; Amal ; et al.	2016-05-26
Methods And Agents For Screening For Compounds Capable Of Modulating Gene Expression App 20150253304 - Cao; Liangxian ; et al.	2015-09-10
Compounds For Treating Spinal Muscular Atrophy App 20150126515 - Chen; Guangming ; et al.	2015-05-07
Compounds For Treating Spinal Muscular Atrophy App 20150119380 - Woll; Matthew G. ; et al.	2015-04-30
Compounds For Treating Spinal Muscular Atrophy App 20150005289 - Qi; Hongyan ; et al.	2015-01-01
Methods of screening for compounds for treating muscular dystrophy using mIGF1 mRNA translation regulation Grant 8,741,572 - Friesen , et al. June 3, 2	2014-06-03
Methods For Treating Spinal Muscular Atrophy App 20140135305 - Paushkin; Sergey V. ; et al.	2014-05-15
Methods for treating spinal muscular atrophy Grant 8,633,019 - Paushkin , et al. January 21, 2	2014-01-21
Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation Grant 8,283,115 - Friesen , et al. October 9, 2	2012-10-09
Methods For Treating Spinal Muscular Atrophy App 20110086833 - Paushkin; Sergey V. ; et al.	2011-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.